Next Generation Digital Natural History Study

CHD2-2.png

What is a Natural History Study and Why Do they Matter?

 

Natural History Studies (NHS) are critical to the drug development process. Ciitizen has developed a new method to make this process easier. A next generation, digital NHS for CHD2-related disorders is expected to facilitate:

  • Informing clinical researchers how a disease changes over time

  • Enabling better endpoint selection to use in clinical trials

  • Understanding the connection between mutation types and symptoms 

  • Reducing the time it takes to study new medicines in clinical trials

  • Speeding up the time to get therapeutics to patients

  • Using data as a placebo (instead of actual patients) in a clinical trial

 

How it Works

  • Participation is completely digital - No clinic visits required

  • Collects participant's medical records from the institutions visited

  • Data from medical records is organized and summarized, free of charge to the participant

  • Participants retain full control of their health records

  • With your consent, clinicians, researchers and biopharma can access anonymized data to aid in research

  • Available now in the US with plans for worldwide availability

  • Registering with Ciitizen requires less than 10 minutes of your time